3.6815
Personalis Inc stock is traded at $3.6815, with a volume of 10,156.
It is down -4.19% in the last 24 hours and down -28.46% over the past month.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$3.82
Open:
$3.66
24h Volume:
10,156
Relative Volume:
0.01
Market Cap:
$315.10M
Revenue:
$73.48M
Net Income/Loss:
$-108.30M
P/E Ratio:
-1.6362
EPS:
-2.25
Net Cash Flow:
$-67.17M
1W Performance:
-15.40%
1M Performance:
-28.46%
6M Performance:
-37.26%
1Y Performance:
+111.24%
Personalis Inc Stock (PSNL) Company Profile
Name
Personalis Inc
Sector
Industry
Phone
650-752-1300
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PSNL
Personalis Inc
|
3.66 | 315.10M | 73.48M | -108.30M | -67.17M | -2.25 |
![]()
TMO
Thermo Fisher Scientific Inc
|
510.25 | 191.99B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
205.63 | 145.87B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
A
Agilent Technologies Inc
|
118.78 | 33.47B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IDXX
Idexx Laboratories Inc
|
412.88 | 33.04B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
IQV
Iqvia Holdings Inc
|
183.09 | 31.99B | 15.41B | 1.37B | 2.11B | 7.50 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-06-23 | Upgrade | Needham | Hold → Buy |
Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Nov-03-21 | Downgrade | Needham | Buy → Hold |
Oct-15-21 | Resumed | Cowen | Outperform |
Sep-20-21 | Reiterated | Needham | Buy |
May-06-21 | Upgrade | Oppenheimer | Perform → Outperform |
Jan-28-21 | Initiated | Truist | Buy |
Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
Nov-12-20 | Reiterated | Needham | Buy |
Nov-06-20 | Downgrade | Oppenheimer | Outperform → Perform |
Oct-19-20 | Initiated | Citigroup | Buy |
Oct-08-20 | Initiated | BTIG Research | Buy |
Aug-27-20 | Initiated | H.C. Wainwright | Buy |
Aug-18-20 | Initiated | Needham | Buy |
Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
Jul-15-19 | Initiated | BofA/Merrill | Neutral |
Jul-15-19 | Initiated | Cowen | Outperform |
Jul-15-19 | Initiated | Morgan Stanley | Overweight |
Jul-15-19 | Initiated | Oppenheimer | Outperform |
View All
Personalis Inc Stock (PSNL) Latest News
Hold Rating for Personalis: Balancing Strong Enterprise Sales and Future Uncertainties - TipRanks
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
Personalis Stock Price, Quotes and Forecasts | NASDAQ:PSNL - Benzinga
Personalis stock target cut to $7 by BTIG, maintains Buy rating - Investing.com Canada
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Yahoo Finance
Personalis’ (PSNL) “Buy” Rating Reiterated at HC Wainwright - Defense World
Needham & Company LLC Cuts Personalis (NASDAQ:PSNL) Price Target to $7.00 - Defense World
Personalis, Inc. (NASDAQ:PSNL) Just Reported Earnings, And Analysts Cut Their Target Price - Simply Wall St
Personalis (NASDAQ:PSNL) Price Target Lowered to $7.00 at Needham & Company LLC - MarketBeat
Personalis Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results - MarketBeat
Personalis stock target cut to $7.00 at Needham, retains buy rating By Investing.com - Investing.com South Africa
Personalis (NASDAQ:PSNL) Announces Earnings Results, Beats Expectations By $0.09 EPS - MarketBeat
Personalis files to sell 14.04M shares of common stock for holders - MSN
Personalis stock target cut to $7.00 at Needham, retains buy rating - Investing.com Canada
Personalis, Inc. (NASDAQ:PSNL) Q4 2024 Earnings Call Transcript - Insider Monkey
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts - Benzinga
Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
ARK Investment Management LLC Sells 310,088 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Personalis: Q4 Earnings Snapshot - Thehour.com
Personalis’ Earnings Call: Growth Amid Challenges - TipRanks
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Personalis Reports 2024 Growth and Strategic Partnerships - TipRanks
Personalis (PSNL) Reports Q4 Loss, Tops Revenue Estimates - MSN
Earnings call transcript: Personalis Q4 2024 beats EPS forecast, stock dips - Investing.com India
Personalis: Q4 Earnings Snapshot -February 27, 2025 at 04:23 pm EST - Marketscreener.com
Personalis price target lowered to $8 from $11 at H.C. Wainwright - MSN
Personalis Inc to Host Earnings Call - ACCESS Newswire
Personalis Inc (PSNL) Q4 2024 Earnings Report Preview: What To L - GuruFocus.com
Personalis Inc (PSNL) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Personalis Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates - MSN
Personalis Inc (NASDAQ: PSNL) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
Personalis (PSNL) to Release Earnings on Thursday - MarketBeat
Personalis (PSNL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Personalis Inc (PSNL) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Personalis (PSNL) Projected to Post Earnings on Wednesday - Defense World
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference - Business Wire
PSNLPersonalis Latest Stock News & Market Updates - StockTitan
297,889 Shares in Personalis, Inc. (NASDAQ:PSNL) Bought by abrdn plc - MarketBeat
Exciting Technology At Personalis, But Profitability Eludes Them (NASDAQ:PSNL) - Seeking Alpha
SG Americas Securities LLC Buys New Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Sumitomo Mitsui Trust Group Inc. Sells 59,295 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results - BioSpace
Cancer Genomics Pioneer Personalis Unveils Q4 Earnings DateKey Details Inside - StockTitan
Understanding the Risks of Investing in Personalis Inc (PSNL) - Knox Daily
Wall Street analysts’ outlook for Personalis Inc (PSNL) - SETE News
Should You Expect A Quick Recovery From Personalis Inc (NASDAQ: PSNL) After -35.08% Decline From High? - Marketing Sentinel
BlackRock, Inc.'s Strategic Acquisition of Personalis Inc. Shares - GuruFocus.com
Personalis Inc (PSNL) is a good investment, but the stock may be overvalued - US Post News
Personalis Inc Stock (PSNL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Personalis Inc Stock (PSNL) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
Moore Stephen Michael | SVP and Chief Legal Officer |
Nov 18 '24 |
Sale |
3.79 |
1,693 |
6,416 |
67,388 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Nov 18 '24 |
Sale |
3.79 |
921 |
3,491 |
128,720 |
Hall Christopher M | PRESIDENT AND CEO |
Nov 01 '24 |
Sale |
5.38 |
26,443 |
142,263 |
178,098 |
Tempus AI, Inc. | 10% Owner |
Aug 16 '24 |
Buy |
5.07 |
3,500,000 |
17,745,000 |
12,718,800 |
Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jul 30 '24 |
Sale |
2.97 |
524 |
1,556 |
127,227 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):